𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predicting outcomes of therapy for prostate carcinoma patients

✍ Scribed by Michael K. Brawer


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
31 KB
Volume
83
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Assessment of outcome prediction models
✍ Anthony V. D'Amico; April Desjardin; Arnold Chung; Ming-Hui Chen; Delray Schultz πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

or neoadjuvant hormonal or radiation therapy were excluded. Akaike's Information Criterion (AIC) and Schwartz Bayesian Criterion (SBC) estimates, which are com-1 Joint Center for Radiation Therapy, Harvard parative measures, were calculated for each clinical staging system. Pairwise com-Medical Scho

Predicting the outcome of radiotherapy f
✍ Edgar Ben-Josef; Falah Shamsa; Jeffrey D. Forman πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

## Background: Clinical research of prostate carcinoma could be enhanced by models that allow early and reliable prediction of outcome. in this study, the authors describe a model-building strategy and compare different models. ## Methods: The sample population was comprised of 158 patients treat

A gleason score of 7 predicts a worse ou
✍ Garth A. Green; Alexandra L. Hanlon; Tahseen Al-Saleem; Gerald E. Hanks πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 94 KB πŸ‘ 2 views

## BACKGROUND. In most reported surgical series, prostate carcinoma patients with a Gleason score of 7 have had worse outcomes than those with other moderately differentiated cancers. Because of variations in reporting grade and grouping Gleason scores, radiation series have conflicting results.

Increased expression of galectin-1 in ca
✍ FrΓ©dΓ©ric A. van den BrΓ»le; David Waltregny; Vincent Castronovo πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 305 KB πŸ‘ 2 views

Galectin-1, a member of the beta-galactoside-binding galectin family, is a pleiotropic dimeric protein participating in a variety of normal and pathological processes, including cancer progression. Modulation of the interactions with the basement membrane glycoprotein laminin and induction of apopto